Cite
APA Citation
Crittenden, M., Bahjat, K., Li, R., Gore, P., Fountain, C., Hanson, B., Skoble, J., Lauer, P., Murphy, A., Dubensky, T., Brockstedt, D., & Urba, W. (2015). phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas. Journal for immunotherapy of cancer, 3(2), 1–2. http://access.bl.uk/ark:/81055/vdc_100080441580.0x0000f3